![](/img/cover-not-exists.png)
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: Efficacy, safety, and clinical benefit assessment
E. Efstathiou, G. Bozas, A. Kostakopoulos, E. Kastritis, C. Deliveliotis, N. Antoniou, D. Skarlos, C. Papadimitriou, M.A. Dimopoulos, A. BamiasVolume:
65
Year:
2005
Language:
english
DOI:
10.1016/j.urology.2004.08.041
File:
PDF, 106 KB
english, 2005